FDA’s 2023 cybersecurity guidance encourages adopting a security-by-design for manufacturing medical devices. Recommend practices include holistic security implementation and deploying technologies for application security testing and supply chain risk analysis. The integration of security checks in continuous integration pipelines and collaboration with stakeholders are also recommended. This update focuses on addressing risks leading to device malfunctions and sensitive data breaches, with potential repercussions like reputational damage and hefty fines.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
